世界の静脈内免疫グロブリン療法市場：市場規模・現状・予測

• 英文タイトル：Global Intravenous Immune Globulin Therapies Market Size, Status and Forecast 2019-2025

• レポートコード：QYR9N7397 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当資料は、静脈内免疫グロブリン療法のグローバル市場について調査・分析したレポートで、種類別（液体フォーム、凍結乾燥粉末フォーム）、用途別（免疫不全、自己免疫疾患、急性感染症）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・静脈内免疫グロブリン療法の世界市場規模 ・主要企業別市場シェア ・静脈内免疫グロブリン療法の世界市場規模：種類別（液体フォーム、凍結乾燥粉末フォーム） ・静脈内免疫グロブリン療法の世界市場規模：用途別（免疫不全、自己免疫疾患、急性感染症） ・静脈内免疫グロブリン療法のアメリカ市場規模（種類別、用途別） ・静脈内免疫グロブリン療法のヨーロッパ市場規模（種類別、用途別） ・静脈内免疫グロブリン療法の中国市場規模（種類別、用途別） ・静脈内免疫グロブリン療法の日本市場規模（種類別、用途別） ・静脈内免疫グロブリン療法の東南アジア市場規模（種類別、用途別） ・静脈内免疫グロブリン療法のインド市場規模（種類別、用途別） ・静脈内免疫グロブリン療法の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・静脈内免疫グロブリン療法の世界市場予測（2019年-2025年） ・静脈内免疫グロブリン療法の地域別市場予測（2019年-2025年） ...

Immune globulin derived from the plasma of paid and volunteer donors is used in the treatment of an array of disorders, including primary and secondary immune deficiency states and a variety of autoimmune and inflammatory disorders.In 2018, the global Intravenous Immune Globulin Therapies market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Intravenous Immune Globulin Therapies status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Intravenous Immune Globulin Therapies development in United States, Europe and China.

The key players covered in this study
Baxter
Grifols
CSL Plasma
Octapharma
Biotest
Kedrion
Kamada
China Biologic Products Holdings
Hualan Biological Engineering
Sichuan Yuanda Shuyang Pharmaceutical

Market segment by Type, the product can be split into
Liquid Form
Lyophilized Powder Form

Market segment by Application, split into
Immunodeficiency
Autoimmune Disease
Acute Infection

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Intravenous Immune Globulin Therapies status, future forecast, growth opportunity, key market and key players.
To present the Intravenous Immune Globulin Therapies development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Intravenous Immune Globulin Therapies are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

---

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Intravenous Immune Globulin Therapies Market Size Growth Rate by Type (2014-2025)
1.4.2 Liquid Form
1.4.3 Lyophilized Powder Form
1.5 Market by Application
1.5.1 Global Intravenous Immune Globulin Therapies Market Share by Application (2014-2025)
1.5.2 Immunodeficiency
1.5.3 Autoimmune Disease
1.5.4 Acute Infection
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Intravenous Immune Globulin Therapies Market Size
2.2 Intravenous Immune Globulin Therapies Growth Trends by Regions
2.2.1 Intravenous Immune Globulin Therapies Market Size by Regions (2014-2025)
2.2.2 Intravenous Immune Globulin Therapies Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Intravenous Immune Globulin Therapies Market Size by Manufacturers
3.1.1 Global Intravenous Immune Globulin Therapies Revenue by Manufacturers (2014-2019)
3.1.2 Global Intravenous Immune Globulin Therapies Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Intravenous Immune Globulin Therapies Market Concentration Ratio (CR5 and HHI)
3.2 Intravenous Immune Globulin Therapies Key Players Head office and Area Served
3.3 Key Players Intravenous Immune Globulin Therapies Product/Solution/Service
3.4 Date of Enter into Intravenous Immune Globulin Therapies Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Intravenous Immune Globulin Therapies Market Size by Type (2014-2019)
4.2 Global Intravenous Immune Globulin Therapies Market Size by Application (2014-2019)

5 United States
5.1 United States Intravenous Immune Globulin Therapies Market Size (2014-2019)
5.2 Intravenous Immune Globulin Therapies Key Players in United States
5.3 United States Intravenous Immune Globulin Therapies Market Size by Type
5.4 United States Intravenous Immune Globulin Therapies Market Size by Application

6 Europe
6.1 Europe Intravenous Immune Globulin Therapies Market Size (2014-2019)
6.2 Intravenous Immune Globulin Therapies Key Players in Europe
6.3 Europe Intravenous Immune Globulin Therapies Market Size by Type
6.4 Europe Intravenous Immune Globulin Therapies Market Size by Application

7 China
7.1 China Intravenous Immune Globulin Therapies Market Size (2014-2019)
7.2 Intravenous Immune Globulin Therapies Key Players in China
7.3 China Intravenous Immune Globulin Therapies Market Size by Type
7.4 China Intravenous Immune Globulin Therapies Market Size by Application

8 Japan
8.1 Japan Intravenous Immune Globulin Therapies Market Size (2014-2019)
8.2 Intravenous Immune Globulin Therapies Key Players in Japan
8.3 Japan Intravenous Immune Globulin Therapies Market Size by Type
8.4 Japan Intravenous Immune Globulin Therapies Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Intravenous Immune Globulin Therapies Market Size (2014-2019)
9.2 Intravenous Immune Globulin Therapies Key Players in Southeast Asia
9.3 Southeast Asia Intravenous Immune Globulin Therapies Market Size by Type
9.4 Southeast Asia Intravenous Immune Globulin Therapies Market Size by Application

10 India
10.1 India Intravenous Immune Globulin Therapies Market Size (2014-2019)
10.2 Intravenous Immune Globulin Therapies Key Players in India
10.3 India Intravenous Immune Globulin Therapies Market Size by Type
10.4 India Intravenous Immune Globulin Therapies Market Size by Application

11 Central & South America
11.1 Central & South America Intravenous Immune Globulin Therapies Market Size (2014-2019)
11.2 Intravenous Immune Globulin Therapies Key Players in Central & South America
11.3 Central & South America Intravenous Immune Globulin Therapies Market Size by Type
11.4 Central & South America Intravenous Immune Globulin Therapies Market Size by Application

12 International Players Profiles
12.1 Baxter
12.1.1 Baxter Company Details
12.1.2 Company Description and Business Overview
12.1.3 Intravenous Immune Globulin Therapies Introduction
12.1.4 Baxter Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
12.1.5 Baxter Recent Development
12.2 Grifols
12.2.1 Grifols Company Details
12.2.2 Company Description and Business Overview
12.2.3 Intravenous Immune Globulin Therapies Introduction
12.2.4 Grifols Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
12.2.5 Grifols Recent Development
12.3 CSL Plasma
12.3.1 CSL Plasma Company Details
12.3.2 Company Description and Business Overview
12.3.3 Intravenous Immune Globulin Therapies Introduction
12.3.4 CSL Plasma Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
12.3.5 CSL Plasma Recent Development
12.4 Octapharma
12.4.1 Octapharma Company Details
12.4.2 Company Description and Business Overview
12.4.3 Intravenous Immune Globulin Therapies Introduction
12.4.4 Octapharma Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
12.4.5 Octapharma Recent Development
12.5 Biotest
12.5.1 Biotest Company Details
12.5.2 Company Description and Business Overview
12.5.3 Intravenous Immune Globulin Therapies Introduction
12.5.4 Biotest Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
12.5.5 Biotest Recent Development
12.6 Kedrion
12.6.1 Kedrion Company Details
12.6.2 Company Description and Business Overview
12.6.3 Intravenous Immune Globulin Therapies Introduction
12.6.4 Kedrion Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
12.6.5 Kedrion Recent Development
12.7 Kamada
12.7.1 Kamada Company Details
12.7.2 Company Description and Business Overview
12.7.3 Intravenous Immune Globulin Therapies Introduction
12.7.4 Kamada Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
12.7.5 Kamada Recent Development
12.8 China Biologic Products Holdings
12.8.1 China Biologic Products Holdings Company Details
12.8.2 Company Description and Business Overview
12.8.3 Intravenous Immune Globulin Therapies Introduction
12.8.4 China Biologic Products Holdings Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
12.8.5 China Biologic Products Holdings Recent Development
12.9 Hualan Biological Engineering
12.9.1 Hualan Biological Engineering Company Details
12.9.2 Company Description and Business Overview
12.9.3 Intravenous Immune Globulin Therapies Introduction
12.9.4 Hualan Biological Engineering Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
12.9.5 Hualan Biological Engineering Recent Development
12.10 Sichuan Yuanda Shuyang Pharmaceutical
12.10.1 Sichuan Yuanda Shuyang Pharmaceutical Company Details
12.10.2 Company Description and Business Overview
12.10.3 Intravenous Immune Globulin Therapies Introduction
12.10.4 Sichuan Yuanda Shuyang Pharmaceutical Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)
12.10.5 Sichuan Yuanda Shuyang Pharmaceutical Recent Development

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details

List of Tables and Figures

Table Intravenous Immune Globulin Therapies Key Market Segments
Table Key Players Intravenous Immune Globulin Therapies Covered
Table Global Intravenous Immune Globulin Therapies Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Intravenous Immune Globulin Therapies Market Size Market Share by Type 2014-2025
Figure Liquid Form Figures
Table Key Players of Liquid Form
Figure Lyophilized Powder Form Figures
Table Key Players of Lyophilized Powder Form
Table Global Intravenous Immune Globulin Therapies Market Size Growth by Application 2014-2025 (Million US$)
Figure Immunodeficiency Case Studies
Figure Autoimmune Disease Case Studies
Figure Acute Infection Case Studies
Figure Intravenous Immune Globulin Therapies Report Years Considered
Table Global Intravenous Immune Globulin Therapies Market Size 2014-2025 (Million US$)
Figure Global Intravenous Immune Globulin Therapies Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Intravenous Immune Globulin Therapies Market Size by Regions 2014-2025 (Million US$)
Table Global Intravenous Immune Globulin Therapies Market Size by Regions 2014-2019 (Million US$)
Table Global Intravenous Immune Globulin Therapies Market Share by Regions 2014-2019
Figure Global Intravenous Immune Globulin Therapies Market Share by Regions 2014-2019
Figure Global Intravenous Immune Globulin Therapies Market Share by Regions 2019
Table Market Top Trends
Table Global Intravenous Immune Globulin Therapies Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Intravenous Immune Globulin Therapies Market Share by Manufacturers (2014-2019)
Figure Global Intravenous Immune Globulin Therapies Market Share by Manufacturers in 2018
Table Global Intravenous Immune Globulin Therapies Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Intravenous Immune Globulin Therapies Product/Solution/Service
Table Date of Enter into Intravenous Immune Globulin Therapies Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Intravenous Immune Globulin Therapies Market Size by Type (2014-2019) (Million US$)
Table Global Intravenous Immune Globulin Therapies Market Size Share by Type (2014-2019)
Figure Global Intravenous Immune Globulin Therapies Market Size Market Share by Type (2014-2019)
Table Global Intravenous Immune Globulin Therapies Market Size by Application (2014-2019) (Million US$)
Table Global Intravenous Immune Globulin Therapies Market Size Share by Application (2014-2019)
Figure Global Intravenous Immune Globulin Therapies Market Size Market Share by Application (2014-2019)
Figure Global Intravenous Immune Globulin Therapies Revenue Market Share by Application in 2018
Figure United States Intravenous Immune Globulin Therapies Market Size 2014-2019 (Million US$)
Table United States Key Players Intravenous Immune Globulin Therapies Revenue (2018-2019) (Million US$)
Table United States Key Players Intravenous Immune Globulin Therapies Market Share (2018-2019)
Table United States Intravenous Immune Globulin Therapies Market Size by Type (2014-2019) (Million US$)
Table United States Intravenous Immune Globulin Therapies Market Share by Type (2014-2019)
Table United States Intravenous Immune Globulin Therapies Market Size by Application (2014-2019) (Million US$)
Table United States Intravenous Immune Globulin Therapies Market Share by Application (2014-2019)
Figure Europe Intravenous Immune Globulin Therapies Market Size 2014-2019 (Million US$)
Table Europe Key Players Intravenous Immune Globulin Therapies Revenue (2018-2019) (Million US$)
Table Europe Key Players Intravenous Immune Globulin Therapies Market Share (2018-2019)
Table Europe Intravenous Immune Globulin Therapies Market Size by Type (2014-2019) (Million US$)
Table Europe Intravenous Immune Globulin Therapies Market Share by Type (2014-2019)
Table Europe Intravenous Immune Globulin Therapies Market Size by Application (2014-2019) (Million US$)
Table Europe Intravenous Immune Globulin Therapies Market Share by Application (2014-2019)
Figure China Intravenous Immune Globulin Therapies Market Size 2014-2019 (Million US$)
Table China Key Players Intravenous Immune Globulin Therapies Revenue (2018-2019) (Million US$)
Table China Key Players Intravenous Immune Globulin Therapies Market Share (2018-2019)
Table China Intravenous Immune Globulin Therapies Market Size by Type (2014-20189) (Million US$)
Table China Intravenous Immune Globulin Therapies Market Share by Type (2014-2019)
Table China Intravenous Immune Globulin Therapies Market Size by Application (2014-2019) (Million US$)
Table China Intravenous Immune Globulin Therapies Market Share by Application (2014-2019)
Figure Japan Intravenous Immune Globulin Therapies Market Size 2014-2019 (Million US$)
Table Japan Key Players Intravenous Immune Globulin Therapies Revenue (2018-2019) (Million US$)
Table Japan Key Players Intravenous Immune Globulin Therapies Market Share (2018-2019)
Table Japan Intravenous Immune Globulin Therapies Market Size by Type (2014-2019) (Million US$)
Table Japan Intravenous Immune Globulin Therapies Market Share by Type (2014-2019)
Table Japan Intravenous Immune Globulin Therapies Market Size by Application (2014-2019) (Million US$)
Table Japan Intravenous Immune Globulin Therapies Market Share by Application (2014-2019)
Figure Southeast Asia Intravenous Immune Globulin Therapies Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Intravenous Immune Globulin Therapies Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Intravenous Immune Globulin Therapies Market Share (2018-2019)
Table Southeast Asia Intravenous Immune Globulin Therapies Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Intravenous Immune Globulin Therapies Market Share by Type (2014-2019)
Table Southeast Asia Intravenous Immune Globulin Therapies Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Intravenous Immune Globulin Therapies Market Share by Application (2014-2019)
Figure India Intravenous Immune Globulin Therapies Market Size 2014-2019 (Million US$)
Table India Key Players Intravenous Immune Globulin Therapies Revenue (2018-2019) (Million US$)
Table India Key Players Intravenous Immune Globulin Therapies Market Share (2018-2019)
Table India Intravenous Immune Globulin Therapies Market Size by Type (2014-2019) (Million US$)
Table India Intravenous Immune Globulin Therapies Market Share by Type (2014-2019)
Table India Intravenous Immune Globulin Therapies Market Size by Application (2014-2019) (Million US$)
Table India Intravenous Immune Globulin Therapies Market Share by Application (2014-2019)
Figure Central & South America Intravenous Immune Globulin Therapies Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Intravenous Immune Globulin Therapies Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Intravenous Immune Globulin Therapies Market Share (2018-2019)
Table Central & South America Intravenous Immune Globulin Therapies Market Size by Type (2014-2019) (Million US$)
Table Central & South America Intravenous Immune Globulin Therapies Market Share by Type (2014-2019)
Table Central & South America Intravenous Immune Globulin Therapies Market Size by Application (2014-2019) (Million US$)
Table Central & South America Intravenous Immune Globulin Therapies Market Share by Application (2014-2019)
Table Baxter Company Details
Table Baxter Revenue in Intravenous Immune Globulin Therapies Business (2014-2019) (Million US$)
Figure Baxter Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2014-2019)
Table Baxter Recent Development
Table Grifols Company Details
Table Grifols Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)(Million US$)
Figure Grifols Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2014-2019)
Table Grifols Recent Development
Table CSL Plasma Company Details
Table CSL Plasma Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)(Million US$)
Figure CSL Plasma Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2014-2019)
Table CSL Plasma Recent Development
Table Octapharma Company Details
Table Octapharma Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)(Million US$)
Figure Octapharma Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2014-2019)
Table Octapharma Recent Development
Table Biotest Company Details
Table Biotest Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)(Million US$)
Figure Biotest Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2014-2019)
Table Biotest Recent Development
Table Kedrion Company Details
Table Kedrion Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)(Million US$)
Figure Kedrion Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2014-2019)
Table Kedrion Recent Development
Table Kamada Company Details
Table Kamada Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)(Million US$)
Figure Kamada Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2014-2019)
Table Kamada Recent Development
Table China Biologic Products Holdings Company Details
Table China Biologic Products Holdings Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)(Million US$)
Figure China Biologic Products Holdings Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2014-2019)
Table China Biologic Products Holdings Recent Development
Table Hualan Biological Engineering Company Details
Table Hualan Biological Engineering Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)(Million US$)
Figure Hualan Biological Engineering Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2014-2019)
Table Hualan Biological Engineering Recent Development
Table Sichuan Yuanda Shuyang Pharmaceutical Company Details
Table Sichuan Yuanda Shuyang Pharmaceutical Revenue in Intravenous Immune Globulin Therapies Business (2014-2019)(Million US$)
Figure Sichuan Yuanda Shuyang Pharmaceutical Revenue Growth Rate in Intravenous Immune Globulin Therapies Business (2014-2019)
Table Sichuan Yuanda Shuyang Pharmaceutical Recent Development
Table Global Intravenous Immune Globulin Therapies Market Size by Regions (Million US$) 2019-2025
Figure Global Intravenous Immune Globulin Therapies Market Size Share by Regions (2019-2025)
Figure Global Intravenous Immune Globulin Therapies Market Size Share by Regions in 2025
Figure United States Intravenous Immune Globulin Therapies Market Size Forecast (2019-2025)(Million USD)
Figure Europe Intravenous Immune Globulin Therapies Market Size Forecast (2019-2025)(Million USD)
Figure China Intravenous Immune Globulin Therapies Market Size Forecast (2019-2025)(Million USD)
Figure Japan Intravenous Immune Globulin Therapies Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Intravenous Immune Globulin Therapies Market Size Forecast (2019-2025)(Million USD)
Figure India Intravenous Immune Globulin Therapies Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Intravenous Immune Globulin Therapies Market Size Forecast (2019-2025)(Million USD)
Table Global Intravenous Immune Globulin Therapies Market Size by Product (2019-2025) (Million US$)
Figure Global Intravenous Immune Globulin Therapies Market Size by Product (2019-2025)
Figure Global Intravenous Immune Globulin Therapies Market Size by Product in 2025
Table Global Intravenous Immune Globulin Therapies Market Size by Application (2019-2025) (Million US$)
Figure Global Intravenous Immune Globulin Therapies Market Size by Application (2019-2025)
Figure Global Intravenous Immune Globulin Therapies Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

---